Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

MyriaMeat

MyriaMeat uses cellular agriculture to develop 100% cell-cultured meat
2022
München, Bayern, Germany

Innovation

Industry Problem

Conventional meat production depends on animal farming, while many cultivated-meat approaches still rely on scaffolds, plant fillers or simplified cell biomass rather than structured muscle tissue.

R&D Focus

Pluripotent stem cells, tissue engineering and scaffold-free cultivation of functional animal muscle.

Innovative Solution

Uses species-specific pluripotent stem cells and controlled tissue-engineering methods to grow structured, contractile muscle tissue without genetic modification or plant-based scaffolds.

Solution Effectiveness

A 2025 hybrid bratwurst prototype contained 20% cultivated meat; the company has also demonstrated a scaffold-free cultivated pork fillet.

About

MyriaMeat is a German cellular agriculture startup that uses medical technology to develop 100% cultivated meat products that do not use plant-based ingredients or scaffolds

Products

Product

Cultivated pork fillet and hybrid bratwurst prototypes containing cultivated muscle tissue.

Star Product

Cultivated pork fillet – demonstrated as 100% muscle tissue without plant fillers or scaffolds.

Demo Product or Complete Product?

Pre-commercial R&D and prototype stage; EU regulatory approval remains pending.

Future Plan

Market Expansion

Targets future European food-industry applications after regulatory approval and scale-up.

Awards and Recognitions

Participations

Featured in the 2025 EY German Biotechnology Report; hybrid-sausage project supported by ERDF and the state of Lower Saxony.

M&A and Collabs

Collab

Hans Kupfer & Sohn – jointly developed a hybrid bratwurst prototype containing 20% cultivated meat.

Something missing or incorrect on this page? Help us enrich this information